News & Events

Filter Year   Keywords   > Submit

Ivantis Announces 3 Year Results of Australian SPECTRUM Registry for Hydrus Microstent

08 / 11 / 2019

> Read More

Ivantis Completes Enrollment of International SPECTRUM Registry for Hydrus Microstent Largest Single-Device Ophthalmic Registry Includes Nearly 3,000 Eyes with 700+ Stand-Alone Glaucoma Procedures

10 / 10 / 2019

> Read More

AirXpanders® Announces Reduction in Force and Plan to Cease Operations

16 / 07 / 2019

> Read More

AirXpanders® Receives FDA 510(k) Clearance for a Smooth Shell Version of the AeroForm® Tissue Expander System

14 / 07 / 2019

> Read More

AirXpanders Announces Strong Revenue Performance in Q2, 2019

08 / 07 / 2019

> Read More

AirXpanders Continues Voluntary Suspension of Trading and Postponement of Annual Meeting of Stockholders

17 / 05 / 2019

> Read More

AirXpanders® Announces Special 510(k) Submission to the US FDA for a Smooth Shell Version of the AeroForm® Tissue Expander System

13 / 05 / 2019

> Read More

Update on Revenue Guidance and Oxford facility

13 / 05 / 2019

> Read More

AirXpanders Engages Cowen to Explore Financial and Strategic Alternatives

08 / 05 / 2019

> Read More

AirXpanders Announces Restructuring to Align Resources and Reduce Use of Cash

02 / 05 / 2019

> Read More

Ivantis Announces Groundbreaking 3 Year Results from FDA Clinical Trial; First Device in Minimally Invasive Glaucoma Surgical (MIGS) Category to Demonstrate Significant Long Term Reduction of Severe Major Surgeries for Glaucoma Patients

02 / 05 / 2019

> Read More

Ivantis Announces Publication of Landmark Comparative MIGS Clinical Trial Results in Leading Ophthalmic Journal

23 / 04 / 2019

> Read More

AirXpanders and Radformation Announce Co-Marketing Agreement 

08 / 04 / 2019

> Read More

AirXpanders Announces New Data Demonstrating Reduced Infection Rates and Decreased Utilization of Healthcare Resources Associated with AeroForm

03 / 04 / 2019

> Read More

AirXpanders Announces Voluntary Suspension of Trading 

02 / 04 / 2019

> Read More

Ivantis Announces 24-Month Results of Landmark Prospective, Randomized Comparative MIGS Clinical Trial

14 / 03 / 2019

> Read More

AirXpanders Provides Update on Strategic Purchasing Agreements with Several Academic Medical Centers

12 / 03 / 2019

> Read More

AirXpanders Announces Support of BRCAStrong Smart Options Medical Panel & Fashion Show

06 / 03 / 2019

> Read More

Appendix 4C – Quarterly Cash Flow Report and Business Update

30 / 01 / 2019

> Read More

 
Displaying 19 records